Antibody Production Market Size, Strategies, Competitive Landscape, Trends & Factor Analysis, 2022–2030

Komentar · 190 Tampilan

The global antibody production market size is expected to reach USD 37.81 Billion in 2030 and register a revenue CAGR of 14.4% during the forecast period.

The global antibody production market size is expected to reach USD 37.81 Billion in 2030 and register a revenue CAGR of 14.4% over the forecast period, according to the latest report by Reports and Data. Rising prevalence of infectious and bacterial diseases, increased investment to accelerate the development of novel antibiotic therapies for infectious diseases, and an increasing number of RD projects to discover and develop new antibiotics are expected to drive market revenue growth during the forecast period. Moreover, antibiotics are often used to avoid contamination in the manufacture of bacterial and viral vaccines, which is another significant reason expected to drive market revenue growth.

Antibodies are used to treat and prevent bacterial and infectious disorders in the healthcare business. Bactericidal drugs kill germs, but bacteriostatic medications inhibit bacteria from dividing and growing. Monoclonal antibodies (mAbs) are used to treat a variety of illnesses, including cancer, rheumatoid arthritis, and other chronic conditions. , While avoiding damage to non-target cells, targeted treatment is growing rapidly, because of its specificity for cancer cells. Targeted medicines are becoming increasingly popular as the incidence of cancer rises. Targeted antibodies are a type of cancer immunotherapy that works by disrupting cancer cell function and alerting the immune system to target and kill cancer cells.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Market Overview:

The global Antibody Production market has significantly grown over the recent past and is expected to register rapid growth over the forecast period. The pharma and healthcare sector is rapidly evolving with innovations in technology, increasing healthcare spending and improving healthcare facilities and systems. Many hospitals, ambulatory surgical care centers and clinics across the globe are adopting advanced devices and equipment. Revenue growth of the global Antibody Production market is significantly driven by factors such as increasing prevalence of chronic diseases, rapid advancements in healthcare and medical sector, high adoption of latest tools and techniques and growing funds by several public and private sectors. In addition, rising focus on drug development, increasing demand for precision medicine, high adoption of home care settings and point-of-care diagnostics, increasing investments in research and development activities are expected to drive global market revenue growth during the forecast period.

Competitive Outlook of the Global Antibody Production Market

The globla Antibody Production market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Antibody Production market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Johnson Johnson Services, Inc., Merck KGaA, Novartis AG, AstraZeneca, AbbVie Inc., Pfizer Inc., Amgen Inc., and GlaxoSmithKline plc.

Inquiry Before Buying @

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Antibody Production Market Segmentation:

Process Type Outlook (Revenue, USD Billion; 2019-2030)

  • Upstream Processing
    • Bioreactors
    • Consumables
  • Downstream Processing
    • Chromatography System
    • Chromatography Resins
  • Filtration
    • Filtration Systems
    • Filtration Consumables Accessories

Antibody Type Outlook (Revenue, USD Billion; 2019-2030)

  • Monoclonal Antibodies (mAbs)
  • Polyclonal Antibodies
  • Other Antibodies

End-use Outlook (Revenue, USD Billion; 2019-2030)

  • Pharmaceutical Biotechnology Companies
  • Diagnostic Laboratories
  • Research Institutes
  • Other End-use

Geographic Segment Covered in the Report:

The Antibody Production report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Glaucoma Treatment Market @

Cryptococcosis Market @

Tuberculosis Testing Market @

Biochips Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370

E-mail: [email protected]